PD Neurotechnology

London, United Kingdom Founded: 2015 • Age: 11 yrs Minicorn
A wearable device is developed to monitor Parkinsons movement disorders.

About PD Neurotechnology

PD Neurotechnology is a Healthcare company based in London (United Kingdom) founded in 2015 by Dimitris Fotiadis, Nikos Moschos, Spyridon Konitsiotis, and Tassos Manos. A wearable device is developed to monitor Parkinsons movement disorders. It operates in the Healthcare and Technology sectors. PD Neurotechnology has raised $93.34 million across 8 funding rounds from investors including SeedBlink, National Bank of Greece and Onassis Foundation. PD Neurotechnology was last valued at $14.71 million in June 2021. PD Neurotechnology offers products and services including PDMonitor®. Its focus areas include HealthTech, Disease Self Management, Neurological Disorders and Monitoring. Its legal entity is PD NEUROTECHNOLOGY LIMITED. Its competitors include GaitQ and Charco Neurotech; 2 of its 2 listed competitors have raised funding.

Company details

PD Neurotechnology was established in 2015 in London, United Kingdom, within the health technology sector. A home-based wearable device is provided for Parkinsons patients to capture kinematic data on motor symptoms and movement disorders. This data is processed via a cloud platform, allowing physicians to review trends, assess disease progression, and recommend tailored treatment plans based on collected metrics.

  • Headquarters London, United Kingdom
  • Founders Dimitris Fotiadis, Nikos Moschos, Spyridon Konitsiotis, Tassos Manos
  • Stage Minicorn
  • Sectors
    Healthcare
    Technology
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website pdneurotechnology.com
  • Social LinkedIn Facebook YouTube
  • Legal Name Pd Neurotechnology Limited
  • Date of Incorporation 30 Sep, 2015
  • Jurisdiction LONDON
Key Metrics
  • Total Equity Funding
    $93.34M (USD)

    in 8 rounds

  • Latest Funding Round
    $2.97M (USD), Series A

    Apr 2023

  • Investors
    SeedBlink

    & 5 more

Products & Services of PD Neurotechnology

PD Neurotechnology offers a comprehensive portfolio of products and services, including PDMonitor®.

PDMonitor®
Medical Device

Wearable system for tracking Parkinson's symptoms and aiding patient care.

Apps and channels of PD Neurotechnology

its YouTube channel PD Neurotechnology has 47 subscribers and 20 videos.

PD Neurotechnology
YouTube 47 subscribers 20 videos Science & Technology
Open channel

Videos from PD Neurotechnology

The most watched videos on PD Neurotechnology's YouTube channel, PD Neurotechnology (47 subscribers). Click a video to play it here.

PDMonitor Ad
1.5K views
PD TRAILER 25 1 21
1.2K views
PD PartA (Telehealth - A Paradigm Shift)
639 views
Professor Fotiadis on Greek National Television
535 views

More on PD Neurotechnology.

Funding Insights of PD Neurotechnology

PD Neurotechnology has successfully raised a total of $93.34M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $2.97 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $93.34M
  • Total Rounds 8
  • Last Round Series A — $2.97M
  • First Round $80.23M

    (Oct 2016)

  • Investors Count 6

All 8 funding rounds of PD Neurotechnology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2023$2.97MSeries A––
Aug 2022$4.98MSeries A–CIC Partners
Jun 2021$100,068Seed$14.71M–
–
Apr 2020$1.64MSeed–Big Pi Ventures
–
Aug 2019$3.05MSeed$14.08M–
–
Jan 2019$287,716Grant––
–
Dec 2018$366,747Seed$•••••–
–
Oct 2016$80.23MSeed$•••••–
–
Valuation history
DateValuationStage
Jun 2021$14.71M••••••••
Aug 2019$14.08M••••••••
Dec 2018$•••••••••••••
Oct 2016$•••••••••••••
Premium access

Full valuation and stage history of PD Neurotechnology

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $14.71M (Jun 2021). 6 investors in total: 6 institutional.

Investors in PD Neurotechnology

PD Neurotechnology has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include SeedBlink, National Bank of Greece and Onassis Foundation.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
A multi-stage technology investment platform is operated globally.
2019bigpi.vcAthens, Greece
CIC Partners is engaged in middle-market private equity investments.
cicpartners.comDallas, United States
Non-profit organization that fosters art, culture, education, and health initiatives through various programs, residencies, and fellowships, promoting creativity, innovation, and social impact
1975onassis.orgAthens, Greece
Investments in pre-seed and seed-stage startups are facilitated for individuals.
2019seedblink.comBucharest, Romania
Retail, corporate, and investment banking services are provided in Greece.
1841nbg.grAthens, Greece
crimsonii.com
Premium access

Investor details for PD Neurotechnology

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of PD Neurotechnology

4 people are tracked at PD Neurotechnology (4 in leadership).

NameRoleGroup
Dimitris Fotiadis
Co-FounderLeadership
Nikos Moschos
Co-FounderLeadership
Spyridon Konitsiotis
Co-FounderLeadership
Tassos Manos
Co-Founder & PartnerLeadership
Premium access

Complete people profiles for PD Neurotechnology

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of PD Neurotechnology

4 dated milestones of PD Neurotechnology across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded PD Neurotechnology is founded.
  2. Funding First funding round of $80.2M.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Series A, of $3.0M.

Competitors of PD Neurotechnology

PD Neurotechnology has 2 listed competitors in our database, 2 of them funded. They include GaitQ and Charco Neurotech.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
gaitq.com2020Oxford, United Kingdom$857,8015
Developer of a device to prevent gait freeze for Parkinson's patients
charconeurotech.com2019Cambridge, United Kingdom$17.25M22
Non-invasive wearable devices for Parkinson's management are developed.
Premium access

Detailed competitors of PD Neurotechnology

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Pd Neurotechnology

Premium access

Complete news archive for PD Neurotechnology

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about PD Neurotechnology

PD Neurotechnology was founded in 2015 and raised its 1st funding round 1 year after it was founded.

PD Neurotechnology is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

PD Neurotechnology is a funded company, having raised a total of $93.34M across 8 funding rounds to date. The company's 1st funding round was a Seed of $80.23M, raised on Oct 2016.

PD Neurotechnology was established in 2015 in London, United Kingdom, within the health technology sector. A home-based wearable device is provided for Parkinsons patients to capture kinematic data on motor symptoms and movement disorders. This data is processed via a cloud platform, allowing physicians to review trends, assess disease progression, and recommend tailored treatment plans based on collected metrics.

PD Neurotechnology's top competitors include Charco Neurotech and GaitQ.

PD Neurotechnology offers PDMonitor®.

PD Neurotechnology has 6 investors. Key investors include SeedBlink, National Bank of Greece, Onassis Foundation, Crimson International Investment, and Big Pi Ventures.

The valuation of PD Neurotechnology is $14.71M as of Jun 2021.

PD Neurotechnology operates through Pd Neurotechnology Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available